Kathryn Martin
Advertisement
Articles by Kathryn Martin
Advertisement
Latest Updated Articles
24 Real-world Use of Neratinib Post-Pertuzumab (P) and –Ado-Trastuzumab Emtansine (T-DM1)Published: April 18th 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Pertuzumab Biosimilar in Breast Cancer Indications
2
FDA Approves Ziftomenib in R/R NPM1-Mutated Acute Myeloid Leukemia
3
Nivolumab/Ipilimumab Improves Real-World Melanoma Outcomes Vs Pembrolizumab
4
FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer
5
